Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutational landscape of severe combined immunodeficiency patients from Turkey.
Firtina S, Yin Ng Y, Hatirnaz Ng O, Kiykim A, Aydiner E, Nepesov S, Camcioglu Y, Sayar EH, Reisli I, Torun SH, Cogurlu T, Uygun D, Simsek IE, Kaya A, Cipe F, Cagdas D, Yucel E, Cekic S, Uygun V, Baris S, Ozen A, Ozbek U, Sayitoglu M. Firtina S, et al. Among authors: hatirnaz ng o. Int J Immunogenet. 2020 Dec;47(6):529-538. doi: 10.1111/iji.12496. Epub 2020 May 22. Int J Immunogenet. 2020. PMID: 32445296
Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.
Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S, Tasar O, Mercan S, Sisko S, Khodzhaev K, Ongoren S, Ar MC, Baslar Z, Soysal T, Sayitoglu M, Ozbek U. Erbilgin Y, et al. Among authors: hatirnaz ng o. Leuk Lymphoma. 2019 Jan;60(1):200-207. doi: 10.1080/10428194.2018.1473573. Epub 2018 Jul 2. Leuk Lymphoma. 2019. PMID: 29965782
Prognostic gene alterations and clonal changes in childhood B-ALL.
Erbilgin Y, Firtina S, Mercan S, Hatirnaz Ng O, Karaman S, Tasar O, Karakas Z, Celkan TT, Zengin E, Sarper N, Yildirmak ZY, Sisko S, Ozbek U, Sayitoglu M. Erbilgin Y, et al. Among authors: hatirnaz ng o. Leuk Res. 2019 Aug;83:106159. doi: 10.1016/j.leukres.2019.05.009. Epub 2019 Jun 8. Leuk Res. 2019. PMID: 31228652 Clinical Trial.
PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia.
Küçükcankurt F, Erbilgin Y, Fırtına S, Hatırnaz Ng Ö, Karakaş Z, Celkan T, Ünüvar A, Özbek U, Sayitoğlu M. Küçükcankurt F, et al. Among authors: hatirnaz ng o. Turk J Haematol. 2020 May 6;37(2):98-103. doi: 10.4274/tjh.galenos.2019.2019.0282. Epub 2019 Nov 20. Turk J Haematol. 2020. PMID: 31744268 Free PMC article.
Copy-number variations in adult patients with chronic immune thrombocytopenia.
Yucesan E, Hatirnaz Ng O, Yalniz FF, Yilmaz H, Salihoglu A, Sudutan T, Eskazan AE, Ongoren S, Baslar Z, Soysal T, Ozbek U, Sayitoglu M, Ar MC. Yucesan E, et al. Among authors: hatirnaz ng o. Expert Rev Hematol. 2020 Nov;13(11):1277-1287. doi: 10.1080/17474086.2020.1819786. Epub 2020 Sep 23. Expert Rev Hematol. 2020. PMID: 32885695
Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.
Erbilgin Y, Hatirnaz Ng O, Can I, Firtina S, Kucukcankurt F, Karaman S, Karakas Z, Celkan TT, Zengin E, Aylan Gelen S, Nihal Ozdemir G, Yildirmak Y, Dogru O, Tansel T, Khodzhaev K, Toluk O, Ozbek U, Sayitoglu M. Erbilgin Y, et al. Among authors: hatirnaz ng o. Int J Lab Hematol. 2021 Oct;43(5):1093-1103. doi: 10.1111/ijlh.13513. Epub 2021 Apr 12. Int J Lab Hematol. 2021. PMID: 33844466
Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G, Ng YY, Eltan SB, Başer D, Ogulur I, Altındirek D, Fırtına S, Yılmaz H, Kocamış B, Kıykım A, Camcıoğlu Y, Ar MC, Sudutan T, Beken S, Temel ŞG, Alanay Y, Karakoc-Aydiner E, Barış S, Özen A, Özbek U, Sayitoğlu M, Hatırnaz Ng Ö. Şentürk G, et al. Among authors: hatirnaz ng o. Scand J Immunol. 2022 Mar;95(3):e13130. doi: 10.1111/sji.13130. Epub 2022 Jan 3. Scand J Immunol. 2022. PMID: 34951041 Free article.
23 results